180 related articles for article (PubMed ID: 9774463)
1. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
[TBL] [Abstract][Full Text] [Related]
3. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
[TBL] [Abstract][Full Text] [Related]
4. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
5. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
Schaufele F
Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
7. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs.
Kumar MB; Tarpey RW; Perdew GH
J Biol Chem; 1999 Aug; 274(32):22155-64. PubMed ID: 10428779
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
[TBL] [Abstract][Full Text] [Related]
9. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
10. The nuclear-receptor interacting protein (RIP) 140 binds to the human glucocorticoid receptor and modulates hormone-dependent transactivation.
Windahl SH; Treuter E; Ford J; Zilliacus J; Gustafsson JA; McEwan IJ
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):93-102. PubMed ID: 10659697
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.
Kumar MB; Perdew GH
Gene Expr; 1999; 8(5-6):273-86. PubMed ID: 10947077
[TBL] [Abstract][Full Text] [Related]
12. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
15. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
Ikonen T; Palvimo JJ; Jänne OA
J Biol Chem; 1997 Nov; 272(47):29821-8. PubMed ID: 9368054
[TBL] [Abstract][Full Text] [Related]
17. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
18. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.
Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH
Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037
[TBL] [Abstract][Full Text] [Related]
19. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1.
Zwijsen RM; Buckle RS; Hijmans EM; Loomans CJ; Bernards R
Genes Dev; 1998 Nov; 12(22):3488-98. PubMed ID: 9832502
[TBL] [Abstract][Full Text] [Related]
20. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
